Table: Towa Pharmaceutical - 9-MTH group results

TOWA PHARMACEUTICAL

14/02/2022 06:01

Feb 14 (Reuters)- 
             Towa Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2021        Dec 31, 2020     Mar 31, 2022 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              125.61              115.25           166.70    
                   (+9.0 pct)          (+36.5 pct)      (+7.6 pct)  
  Operating           16.99               14.79            19.30    
                   (+14.9 pct)         (+4.7 pct)       (-3.1 pct)  
  Recurring           21.06               13.05            22.11    
                   (+61.4 pct)         (-15.5 pct)      (+18.4 pct) 
  Net                 15.00                9.45            15.44    
                   (+58.8 pct)         (-13.9 pct)      (+10.6 pct) 
  EPS              304.80 yen          191.96 yen       313.73 yen  
  EPS Diluted      298.05 yen          187.48 yen                   
  Ann Div                               44.00 yen        60.00 yen  
  -Q2 div           27.00 yen           22.00 yen                   
  -Q4 div                               22.00 yen        33.00 yen  
  
  NOTE - Towa Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T